-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The link between body mass index (BMI) and COVID-19 is not fully understood
.
Recently, a research article was published in the Journal of Clinical Endocrinology & Metabolism, an authoritative journal in the field of endocrine and metabolic diseases, which aims to investigate BMI and COVID-19 diagnosis , COVID-19 hospitalization, and the risk of death after COVID-19 diagnosis or hospitalization The association (subsequent death) and the potential impact of adjusting for age and gender
.
In this population-based cohort study, more than 80% of Catalan primary care records were linked to regional testing, hospital, and mortality records between March and May 2020
.
Participants are adults (≥18 years old) who have had their weight and height measured at least once
Risk ratio of COVID-19 outcome related to body mass index
The study included 2524926 participants
.
After 67 days of follow-up, 57,443 people were diagnosed with COVID-19, 10,862 were hospitalized due to COVID-19, and 2467 died subsequently
It can be seen that there is an association between BMI and COVID-19 diagnosis and hospitalization risk, but there is a J-type association with mortality
.
More research is needed to unravel the mechanisms behind these associations
There is an association between BMI and COVID-19 diagnosis and hospitalization risk, but there is a J-type association with mortality
Original source:
Original source:Martina Recalde.
Body mass index and risk of COVID- 19 diagnosis, hospitalisation, and death: a cohort study of 2 524 926 Catalans in this message
